ACTRN12611000961943已完成未知
For people with bipolar disorder, does participation in a Bipolar Disorder Clinic providing Interpersonal and Social Rhythm Therapy and medication management increase the time to relapse compared to usual care?
niversity of Otago, Christchurch0 个研究点目标入组 88 人开始时间: 2011年9月7日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 88
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Treatment
- 盲法
- Blinded (masking used)
入排标准
- 年龄范围
- 18 Years 至 70 Years（—）
- 性别
- All
入选标准
- •Patients with a diagnosis of bipolar disorder discharged from specialty mental health services.
排除标准
- •Exclusion criteria will be the primary diagnosis of a serious mental disorder such as schizophrenia or severe alcohol and drug dependence
研究者
相似试验
招募中
Unknown
A Randomized, Double-Blind, Parallel Group Clinical Study To Evaluate Efficacy And Safety Of UO ABG 01 In The Management Of Borderline Cardio Vascular Risk FactorsCTRI/2023/10/058501Xtractiva Life Science Private Limited
进行中（未招募）
1 期
A randomized, double-blind, parallel group clinical trial to assess safety, tolerability, pharmacokinetics, and pharmacodynamics of intravenous mepolizumab (SB240563) (0.55mg/kg, 2.5mg/kg or 10mg/kg) in pediatric subjects with eosinophilic esophagitis, aged 2 to 17 years - Mepolizumab in paediatric eosinophilic oesophagitisEosinophilic oesophagitisEUCTR2005-006074-10-GBGlaxoSmithKline Research & Development Ltd.72
进行中（未招募）
1 期
Comparison of Vortioxetine and Desvenlafaxine in Adult Patients Suffering From Depression ( VIVRE )EUCTR2019-002704-41-ESH. Lundbeck A/S600
进行中（未招募）
不适用
A study of the new pharmaceutical LuAA21004 in comparison to agomelatine in adults suffering from major depression who did not respond well to previous medication.-Major Depressive Disorder (MDD)MedDRA version: 14.1Level: LLTClassification code 10025453Term: Major depressive disorder NOSSystem Organ Class: 100000004873EUCTR2011-002362-21-CZH. Lundbeck A/S500
进行中（未招募）
1 期
Comparison of Vortioxetine and Desvenlafaxine in Adult Patients Suffering From Depression ( VIVRE )EUCTR2019-002704-41-CZH. Lundbeck A/S600